Literature DB >> 31894481

Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China.

Jun Lu1,2, Changhwan Yoon2, Binbin Xu1, Jianwei Xie1, Ping Li1, Chaohui Zheng1, Changming Huang1, Sam S Yoon3.   

Abstract

BACKGROUND: This study aimed to compare the long-term survival of patients undergoing minimally invasive gastrectomy and those undergoing open gastrectomy for gastric adenocarcinoma (GA) in the United States and China.
METHODS: Data on patients with GA who underwent gastrectomy without neoadjuvant therapy were retrieved from prospectively maintained databases at Memorial Sloan Kettering Cancer Center (MSKCC) and Fujian Medical University Union Hospital (FMUUH). Using propensity score-matching (PSM), equally sized cohorts of patients with similar clinical and pathologic characteristics who underwent minimally invasive versus open gastrectomy were selected. The primary end point of the study was 5-year overall survival (OS).
RESULTS: The study identified 479 patients who underwent gastrectomy at MSKCC between 2000 and 2012 and 2935 patients who underwent gastrectomy at FMUUH between 2006 and 2014. Of the total 3432 patients, 1355 underwent minimally invasive gastrectomy, and 2059 underwent open gastrectomy. All the patients had at least 5 years of potential follow-up evaluation. Before PSM, most patient characteristics differed significantly between the patients undergoing the two types of surgery. After PSM, each cohort included 889 matched patients, and the actual 5-year OS did not differ significantly between the two cohorts, with an OS rate of 54% after minimally invasive gastrectomy and 50.4% after open gastrectomy (p = 0.205). Subgroup analysis confirmed that survival was similar between surgical cohorts among the patients for each stage of GA and for those undergoing distal versus total/proximal gastrectomy. In the multivariable analysis, surgical approach was not an independent prognostic factor.
CONCLUSIONS: After PSM of U.S. and Chinese patients with GA undergoing gastrectomy, long-term survival did not differ significantly between the patients undergoing minimally invasive gastrectomy and those undergoing open gastrectomy.

Entities:  

Mesh:

Year:  2020        PMID: 31894481      PMCID: PMC7004868          DOI: 10.1245/s10434-019-08170-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  ASO Author Reflections: Minimally Invasive Surgery for Gastric Cancer-Has the Future Arrived?

Authors:  Jun Lu; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2020-03-03       Impact factor: 5.344

2.  Risk of Lymph Node Metastasis in T1b Gastric Cancer: An International Comprehensive Analysis from the Global Gastric Group (G3) Alliance.

Authors:  Elvira L Vos; Masaya Nakauchi; Mithat Gönen; Jason A Castellanos; Alberto Biondi; Daniel G Coit; Johan L Dikken; Domenico D'Ugo; Henk Hartgrink; Ping Li; Makoto Nishimura; Mark Schattner; Kyo Young Song; Laura H Tang; Ichiro Uyama; Santosha Vardhana; Rob H A Verhoeven; Bas P L Wijnhoven; Vivian E Strong
Journal:  Ann Surg       Date:  2021-12-14       Impact factor: 13.787

Review 3.  Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes.

Authors:  Mason D Stillman; Sam S Yoon
Journal:  J Surg Oncol       Date:  2022-04-13       Impact factor: 2.885

4.  Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States.

Authors:  Joon Y Park; Arjun Verma; Zachary K Tran; Michael A Mederos; Peyman Benharash; Mark Girgis
Journal:  Ann Surg Oncol       Date:  2022-01-07       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.